Dimopoulos, M. A., Palumbo, A., Hajek, R., Kropff, M., Petrucci, M. T., Lewis, P., . . . Delforge, M. (2014). Factors that influence health-related quality of life in newly diagnosed patients with multiple myeloma aged ≥ 65 years treated with melphalan, prednisone and lenalidomide followed by lenalidomide maintenance: Results of a randomized trial. Informa Healthcare.
Citación estilo ChicagoDimopoulos, Meletios A., et al. Factors That Influence Health-related Quality of Life in Newly Diagnosed Patients With Multiple Myeloma Aged ≥ 65 Years Treated With Melphalan, Prednisone and Lenalidomide Followed By Lenalidomide Maintenance: Results of a Randomized Trial. Informa Healthcare, 2014.
Cita MLADimopoulos, Meletios A., et al. Factors That Influence Health-related Quality of Life in Newly Diagnosed Patients With Multiple Myeloma Aged ≥ 65 Years Treated With Melphalan, Prednisone and Lenalidomide Followed By Lenalidomide Maintenance: Results of a Randomized Trial. Informa Healthcare, 2014.